Sig-1R stimulation with fluvoxamine alters the current kinetics of Ito and hyperpolarizes the steady-state activation of ICa-L while improving depression and prolonging the QTc interval under CUMS [26]. Here, SIGMAR1 is linked to depressive symptom measurement.